-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Investigating Nuclear Transport Inhibition in Myelofibrosis (MF) and Myelodysplastic Neoplasms (MDS)

Sponsor: Karyopharm Therapeutics, Inc
Program: Industry Theaters
Sunday, December 11, 2022: 11:30 AM-12:30 PM
Hall J - Theater 5 (Ernest N. Morial Convention Center)
Speaker:
Reshma Rangwala, MD, PhD, Karyopharm Therapeutics, Inc.
Disclosures:
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Industry Theaters
<< Previous Session | Next Session >>